| Jun 17 |
EHA 2024: Novartis Scemblix takes on all TKIs in head-to-head CML trial
|
| Jun 11 |
Is Novartis AG (NYSE:NVS) Investors’ Favorite International Dividend Stock?
|
| Jun 6 |
Why Novartis (NVS) is a Top Value Stock for the Long-Term
|
| Jun 6 |
Novartis, Roche facing Italy antitrust probe over Lucentis biosimilar
|
| Jun 6 |
Germany’s ITM raises $205M as radiopharma field booms
|
| Jun 4 |
The 3 Most Undervalued Healthcare Stocks to Buy in June 2024
|
| Jun 4 |
Why Novartis (NVS) is a Top Momentum Stock for the Long-Term
|
| Jun 3 |
Novartis AG (NVS) Investor Event at ASCO Conference Call (Transcript)
|
| May 31 |
Novartis (NVS) Reports Positive Long-Term Data on CSU Drug
|
| May 31 |
Novartis boasts Scemblix beats tyrosine kinase inhibitors for chronic myeloid leukemia
|
